Company / EPS (Diluted)
Bionano Genomics, Inc. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$88.13
FY2025
5-year range
-$408.60 / -$0.26
FY2021-FY2025
Trend
+78.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-88.13.
Based on SEC 10-K filings.
-88.13 in FY2025.
Declined from $-4.58 to $-88.13 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 78.4% year-over-year.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$88.13 | +78.4% |
| FY2024 | -$408.60 | -8821.4% |
| FY2023 | -$4.58 | -1661.5% |
| FY2022 | -$0.26 | +33.3% |
| FY2021 | -$0.39 | +80.4% |
| FY2020 | -$1.99 | +23.8% |
| FY2019 | -$2.61 | +69.8% |
| FY2018 | -$8.65 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026